ÂÜÀòÂÒÂ×

Sandra Rivas MSc, RAC is a seasoned regulatory affairs professional with a focus in gene therapy and rare diseases, currently serving as the Senior Director of Regulatory Affairs at Sarepta Therapeutics. Rivas has held prominent roles including President of RCG Real Estate Holdings, LLC, and Director of Regulatory Affairs at BeiGene, where the expertise in immuno-oncology and oncology was developed. Additional experience includes leadership positions at Precision For Medicine and Halloran Consulting Group, emphasizing consulting services in oncology and rare diseases. Rivas has enhanced knowledge through education at Harvard Business School Executive Education and holds a certificate in Advanced Biosciences from the University of California, Berkeley.